Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hyperlipoproteinemias

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 23 articles:
HTML format
Text format



Single Articles


    August 2018
  1. BALLANTYNE CM, Bhatt DL, Cannon CP, Fazio S, et al
    Raising the Bar by Lowering the Target: Integrating PCSK9 Inhibitors Into Hypercholesterolemia Management.
    Am J Cardiol. 2018 Aug 16. pii: S0002-9149(18)31653.
    PubMed     Text format     Abstract available


    July 2018
  2. NICHOLS GA, Philip S, Reynolds K, Granowitz CB, et al
    Comparison of Medical Care Utilization and Costs Among Patients With Statin-Controlled Low-Density Lipoprotein Cholesterol With Versus Without Hypertriglyceridemia.
    Am J Cardiol. 2018 Jul 5. pii: S0002-9149(18)31321.
    PubMed     Text format     Abstract available


    February 2018
  3. KARALIS DG, Mallya UG, Ghannam AF, Elassal J, et al
    Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30185.
    PubMed     Text format     Abstract available


  4. MCCULLOUGH PA, Ballantyne CM, Sanganalmath SK, Langslet G, et al
    Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
    Am J Cardiol. 2018 Feb 2. pii: S0002-9149(18)30093.
    PubMed     Text format     Abstract available


    September 2017
  5. EL SHAHAWY M, Cannon CP, Blom DJ, McKenney JM, et al
    Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II).
    Am J Cardiol. 2017;120:931-939.
    PubMed     Text format     Abstract available


    August 2017
  6. TADA H, Kawashiri MA, Okada H, Nakahashi T, et al
    Assessments of Carotid Artery Plaque Burden in Patients With Familial Hypercholesterolemia.
    Am J Cardiol. 2017 Aug 30. pii: S0002-9149(17)31382.
    PubMed     Text format     Abstract available


    July 2017
  7. SATTAR N, Toth PP, Blom DJ, Koren MJ, et al
    Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31220.
    PubMed     Text format     Abstract available


    April 2017
  8. BALLANTYNE CM, Shah S, Sapre A, Ashraf TB, et al
    A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30626.
    PubMed     Text format     Abstract available


    February 2017
  9. KOSMIDOU I, Redfors B, Dordi R, Dizon JM, et al
    Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
    Am J Cardiol. 2017 Feb 16. pii: S0002-9149(17)30118.
    PubMed     Text format     Abstract available


  10. MOSCA L, Ballantyne CM, Bays HE, Guyton JR, et al
    Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials).
    Am J Cardiol. 2017;119:397-403.
    PubMed     Text format     Abstract available


    January 2017
  11. ZAFRIR B, Jaffe R, Rubinshtein R, Karkabi B, et al
    Impact of Diabetes Mellitus on Long-Term Mortality in Patients Presenting for Coronary Angiography.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30049.
    PubMed     Text format     Abstract available


  12. GAUDET D, Watts GF, Robinson JG, Minini P, et al
    Effect of Alirocumab on Lipoprotein(a) Over >/=1.5 Years (from the Phase 3 ODYSSEY Program).
    Am J Cardiol. 2017;119:40-46.
    PubMed     Text format     Abstract available


    December 2016
  13. JONES PH, Bays HE, Chaudhari U, Pordy R, et al
    Safety of Alirocumab (A PCSK9 Monoclonal Antibody) from 14 Randomized Trials.
    Am J Cardiol. 2016;118:1805-1811.
    PubMed     Text format     Abstract available


  14. PEREZ-CALAHORRA S, Sanchez-Hernandez RM, Plana N, Marco-Benedi V, et al
    Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.
    Am J Cardiol. 2016 Dec 2. pii: S0002-9149(16)31894.
    PubMed     Text format     Abstract available


    November 2016
  15. NICHOLS GA, Reynolds K, Olufade T, Kimes TM, et al
    Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31740.
    PubMed     Text format     Abstract available


  16. BALLANTYNE CM, Shah S, Kher U, Hunter JA, et al
    Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    Am J Cardiol. 2016 Nov 1. pii: S0002-9149(16)31743.
    PubMed     Text format     Abstract available


    September 2016
  17. BLAHA MJ
    Personalizing Treatment: Between Primary and Secondary Prevention.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available


  18. TOTH PP
    Novel Therapies for Low-Density Lipoprotein Cholesterol Reduction.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available


  19. MIEDEMA MD, Virani SS
    Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies.
    Am J Cardiol. 2016;118.
    PubMed     Text format     Abstract available


  20. TOTH PP, Catapano AL, Farnier M, Foody J, et al
    Effect on Fasting Serum Glucose Levels of Adding Ezetimibe to Statins in Patients With Nondiabetic Hypercholesterolemia.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31478.
    PubMed     Text format     Abstract available


  21. KONISHI H, Miyauchi K, Shitara J, Endo H, et al
    Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31474.
    PubMed     Text format     Abstract available


    July 2016
  22. TERAMOTO T, Kobayashi M, Uno K, Takagi Y, et al
    Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies).
    Am J Cardiol. 2016;118:56-63.
    PubMed     Text format     Abstract available


    May 2016
  23. HECHT EM, Arheart KL, Lee DJ, Hennekens CH, et al
    Interrelation of Cadmium, Smoking, and Cardiovascular Disease (from the National Health and Nutrition Examination Survey).
    Am J Cardiol. 2016 May 4. pii: S0002-9149(16)30560.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: